Comparison of hexaminolevulinate (HAL) -guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparison of hexaminolevulinate (HAL) -guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized controlled trials

Published:2023-03 Issue: Volume:41 Page:103220
ISSN:1572-1000
Container-title:Photodiagnosis and Photodynamic Therapy
language:en
Short-container-title:Photodiagnosis and Photodynamic Therapy

Author:

Zhao Hang,Peng Panxin,Luo Zhenkai,Liu Hailong,Sun Junwei,Wang Xuming,Jia Qiang,Yang Zhihao

Publisher

Elsevier BV

Subject

Pharmacology (medical),Dermatology,Oncology,Biophysics

Reference58 articles.

1. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur. Urol.,2022

2. Treatment changes and long-term recurrence rates after hexaminolevulinate (Hal) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (Nmibc)?;Geavlete;BJU Int.,2011

3. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using eortc risk tables: a combined analysis of 2596 patients from seven Eortc trials;Sylvester;Eur. Urol.,2006

4. A Second-look Tur in T1 transitional cell carcinoma: why?;Jakse;Eur. Urol.,2004

5. Mechanisms of recurrence of Ta/T1 bladder cancer;Bryan;Ann. R. Coll. Surg. Engl.,2010

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. Validation of a White Light and Fluorescence Augmented Panoramic Endoscopic Imaging System on a Bimodal Bladder Wall Experimental Model;Photonics;2024-05-28

3. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment;Journal of Urology;2024-04